<DOC>
	<DOCNO>NCT00169559</DOCNO>
	<brief_summary>An eight week comparison investigational drug GW590735 , placebo , market drug fenofibrate intend increase level `` good cholesterol '' decrease level `` bad cholesterol '' healthy patient low level good cholesterol high level bad cholesterol .</brief_summary>
	<brief_title>Dyslipidemia Study Investigating The Increase In `` Good Cholesterol ''</brief_title>
	<detailed_description>A multi-center , three-staged , randomize , parallel group , sequential , double-blind , fenofibrate-and placebo-controlled dose-response evaluation safety , tolerability , effect plasma HDLc TG eight week treatment 1µg 20µg daily dos GW590735 otherwise healthy subject low HDLc , mildly moderately elevated TG , normal LDLc</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>Inclusion criterion : Highdensity lipoprotein cholesterol le equal 45 mg/dL . Triglycerides great equal 120 mg/dL less equal 500 mg/dL . Women must surgically sterile postmenopausal . Exclusion criterion : Heart disease Diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>triglyceride</keyword>
	<keyword>Hypertriglyceridemia</keyword>
	<keyword>cholesterol</keyword>
	<keyword>LDL</keyword>
	<keyword>HDL</keyword>
</DOC>